March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Large Novel ALMS1 Gene Deletion Detected In Chinese Families With AlströM Syndrome
Author Affiliations & Notes
  • Yang Li
    Beijing Inst of Ophthalmology, Beijing Tongren Hospital, Beijing, China
  • ZHE PAN
    Beijing Inst of Ophthalmology, Beijing Tongren Hospital, Beijing, China
  • BING DONG
    Beijing Inst of Ophthalmology, Beijing Tongren Hospital, Beijing, China
  • XIAOHUI ZHANG
    Beijing Inst of Ophthalmology, Beijing Tongren Hospital, Beijing, China
  • Footnotes
    Commercial Relationships  Yang Li, None; ZHE Pan, None; BING Dong, None; XIAOHUI Zhang, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 1570. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yang Li, ZHE PAN, BING DONG, XIAOHUI ZHANG; Large Novel ALMS1 Gene Deletion Detected In Chinese Families With AlströM Syndrome. Invest. Ophthalmol. Vis. Sci. 2012;53(14):1570.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Alström syndrome (OMIM: 203800) is a rare and severe autosomal recessive disorder with five clinical features including atypical retinal pigmentary degeneration, sensorineural hearing loss, obesity, type II diabetes mellitus, and normal mentation(1). The single disease causing gene is the ALMS1 gene located in the chromosome 2 p13.1. The current study described the clinical and genetic findings in two Chinese families with Alström syndrome.

Methods: : Two unrelated families were examined clinically. After informed consent was obtained, genomic DNA was extracted from the venous blood of all participants. Exon 8, 10, 16 of the ALMS1 gene was amplified by polymerase chain reaction (PCR). The PCR products were analyzed using direct sequencing. Large deletion was analyzed by real-time quantitative PCR (RQ-PCR) using all 23 exons primers of the ALMS1 gene. Long-range PCR followed by DNA sequencing was used to define the breakpoints.

Results: : By clinical examination and laboratory investigations, three individuals from the two families were diagnosed of Alström syndrome. All patients presented congenital progressive atypical retinal pigmentary degeneration, sensorineural deafness, infantile onset obesity, diabetic, hepatic and renal dysfunction, and normal intelligence. Sequencing of part of the ALMS1 gene identified two novel heterozygous small deletions: c. 4145delACTC (p. S1383FS) in family F1 and c.9460delG (p. V3154X) in family F2, one novle heterozygous insert mutation c.9452insAATA (p.S3151fs) in family F2. A 199.3kb large deletion, which encompassed exon 3-23 of the ALMS1 gene, was identified in family F1. All novel mutations were co-segregated with the phenotype of the two families, but were not found in 100 normal controls.

Conclusions: : A large deletion was first identified in the ALMS1 gene; the ALMS1 gene mutation screen can provide the genetic counseling for the families of Alström syndrome and is important for the diagnosis of the cases with atypical clinical features.

Keywords: gene screening • mutations • retinal degenerations: hereditary 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×